HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tzung-Yan Lee Selected Research

yin-chen-hao-tang

4/2009Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang.
4/2007Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats.
1/2007Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tzung-Yan Lee Research Topics

Disease

19Fibrosis (Cirrhosis)
01/2021 - 11/2003
18Inflammation (Inflammations)
02/2022 - 04/2009
10Neoplasms (Cancer)
02/2022 - 04/2009
9Portal Hypertension
02/2022 - 04/2005
7Fatty Liver
10/2021 - 06/2010
7Obesity
07/2021 - 06/2009
7Mitochondrial Diseases (Mitochondrial Disease)
07/2021 - 09/2012
7Liver Diseases (Liver Disease)
09/2015 - 01/2007
5Hypoxia (Hypoxemia)
07/2021 - 01/2014
5Non-alcoholic Fatty Liver Disease
07/2021 - 05/2012
4Body Weight (Weight, Body)
02/2022 - 06/2009
4Insulin Resistance
10/2021 - 05/2015
4Liver Cirrhosis (Hepatic Cirrhosis)
08/2019 - 11/2003
4Necrosis
03/2018 - 05/2009
3Colitis
02/2022 - 01/2020
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2016 - 04/2014
3Cholestasis
05/2009 - 01/2007
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2009 - 05/2007
2Dysbiosis
02/2022 - 01/2021
2Infections
01/2020 - 11/2014
2Ascites
01/2020 - 11/2014
2Hepatitis
01/2020 - 01/2017
2Alcoholic Fatty Liver
01/2019 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 12/2016
2Carcinoma (Carcinomatosis)
12/2016 - 09/2015
1Colitis-Associated Neoplasms
02/2022
1Carcinogenesis
02/2022
1Muscular Atrophy (Muscle Atrophy)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Low Back Pain (Lumbago)
10/2020
1Ulcerative Colitis
01/2020
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2020
1Hyperplasia
01/2020
1Hepatorenal Syndrome
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Chronic Renal Insufficiency
01/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019
1Herpes Zoster
01/2019

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2020 - 11/2012
5Proteins (Proteins, Gene)FDA Link
07/2021 - 11/2012
5Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2017 - 08/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2019 - 12/2014
4andrographolideIBA
01/2019 - 08/2010
4LipopolysaccharidesIBA
03/2018 - 04/2009
4CannabinoidsIBA
11/2014 - 02/2006
4Bile Acids and Salts (Bile Acids)IBA
08/2010 - 01/2007
3Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2016
3AntioxidantsIBA
01/2022 - 05/2015
3Losartan (Cozaar)FDA LinkGeneric
10/2021 - 01/2014
3Sirtuin 1IBA
01/2021 - 01/2017
3Propranolol (Inderal)FDA LinkGeneric
01/2020 - 03/2015
3CreatinineIBA
01/2020 - 02/2018
3Messenger RNA (mRNA)IBA
03/2018 - 11/2012
3Alanine Transaminase (SGPT)IBA
02/2018 - 11/2012
3Thioacetamide (Thioacetamid)IBA
12/2014 - 07/2014
3yin-chen-hao-tangIBA
04/2009 - 01/2007
2Vasoconstrictor AgentsIBA
02/2022 - 04/2005
2Insulin (Novolin)FDA Link
01/2022 - 03/2016
2NF-kappa B (NF-kB)IBA
08/2019 - 04/2009
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2019 - 01/2009
2Caspase 3 (Caspase-3)IBA
01/2019 - 11/2012
22- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA
01/2019 - 01/2019
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019 - 01/2019
2GW 4064IBA
03/2018 - 01/2017
2Therapeutic UsesIBA
09/2015 - 04/2009
2Nonesterified Fatty Acids (NEFA)IBA
05/2015 - 09/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2014 - 05/2012
2CurcuminIBA
09/2012 - 09/2012
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2012 - 04/2009
2EndocannabinoidsIBA
05/2012 - 05/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 04/2005
2Oxidants (Oxidizing Agents)IBA
01/2007 - 11/2003
2Carbon Tetrachloride (Tetrachloromethane)IBA
05/2006 - 11/2003
1corylinIBA
02/2022
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
02/2022
1Dextrans (Dextran)FDA Link
02/2022
1Lipoproteins (Lipoprotein)IBA
01/2022
1Sucrose (Saccharose)IBA
01/2022
1Ligases (Synthetase)IBA
01/2022
1Endothelial Growth FactorsIBA
01/2022
1Amino AcidsFDA Link
01/2022
1PerilipinsIBA
07/2021
1Angiotensin Receptor AntagonistsIBA
07/2021
1Transcription Factors (Transcription Factor)IBA
07/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2020
1Lipocalin-2IBA
01/2020
1obeticholic acidIBA
01/2020
1Dextran SulfateIBA
01/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2019
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2019
1ProcollagenIBA
08/2019
1intrinsic factor-cobalamin receptorIBA
01/2019
1methylallyl trisulfide (MATS)IBA
01/2019

Therapy/Procedure

8Ligation
02/2022 - 04/2006
5Electroacupuncture
02/2022 - 01/2014
5Therapeutics
10/2017 - 11/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2017 - 06/2014
2Oral Administration
02/2018 - 07/2014
2Chemoprevention
06/2011 - 04/2009